Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients. (Q48954062)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Friedemann Paul

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Nicolas Collongues

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Jerome de Seze

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

M Mealy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

A Jacob

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

I Nakashima

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

P Cabre

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

S Bigi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

S Jarius

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

O Aktas

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

L Elsone

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

K Mutch

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

M Levy

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Y Takai

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

B Banwell

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

K Fujihara

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

publication date

7 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

27 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

843-847

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

The clinical course of neuromyelitis optica (Devic's syndrome).

27 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Revised diagnostic criteria for neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Multiple sclerosis in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Devic disease with brainstem lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Prominent brainstem symptoms/signs in patients with neuromyelitis optica in a Taiwanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Descriptive epidemiology of neuromyelitis optica in the Caribbean basin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Role of return migration in the emergence of multiple sclerosis in the French West Indies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

An epidemiological study of neuromyelitis optica in Cuba

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Intractable nausea and vomiting from autoantibodies against a brain water channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Spectrum disorder of neuromyelitis optica in a patient presenting with intractable vomiting and hiccups, transverse myelitis and acute encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

[Intractable vomiting as first manifestation of neuromyelitis Optica].

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Hiccups, nausea, and vomiting: water channels under attack!

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Unusual manifestations of pediatric neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Neuropathic pruritus (itch) in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Hypogeusia as a symptom of neuromyelitis optica spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Where Do AQP4 Antibodies Fit in the Pathogenesis of NMO?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Immunosuppressive therapy is more effective than interferon in neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Failure of natalizumab to prevent relapses in neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Does natalizumab therapy worsen neuromyelitis optica?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513507822

21 January 2018

Identifiers

DOI

10.1177/1352458513507822

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099751%20AND%20SRC:MED&resulttype=core&format=json

release_p3ngtgacxngtlbu7sfwlr3kfia

27 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/p3ngtgacxngtlbu7sfwlr3kfia

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference